Post-Void Residual: The Voiding-Impairment Gate-Check

Post-void residual is the volume of urine remaining in the bladder immediately after a voluntary void. The IPC clinical-practice cutoff is <100 mL normal, 100 to 300 mL indeterminate and worth investigating, >300 mL clinically significant retention warranting urology referral. PVR is the single diagnostic that separates Storage-axis from Voiding-axis impairment in the IPC 4Is functional framework, and the test that, more than any other in the bladder workup, reorganises the differential.

A 58-year-old woman starts an 8-week pelvic-floor strengthening program for what was charted as stress urinary incontinence. Six weeks in, she returns worse, not better. New urgency. New daytime frequency. New sensation of fullness she cannot explain. The treating PT, suspecting the strengthening program has failed, scans her bladder. Post-void residual returns at 280 mL. The leaks were never stress incontinence. They were overflow. The kegel program had been compounding the underlying problem.

This is the move the post-void residual asks for in any bladder workup that takes the 4Is framework seriously: read the PVR before you commit to a treatment axis. Misreading Voiding Impairment as Storage Impairment, or vice versa, is the most common pattern that produces stuck cases in pelvic-health practice. PVR is the test that prevents that misread. Cleveland Clinic, StatPearls, and the urology literature all describe how to measure it (Asimakopoulos et al, Neurourology and Urodynamics 2016). What this article walks is how a clinician at the bedside, in particular the pelvic-floor PT, primary care physician, or advanced-practice provider seeing the patient first, uses the result to decide what happens next.

Why post-void residual is the keystone of the bladder workup

Bladder symptoms, particularly the urgency-frequency presentations that account for most LUTS visits, look identical from the chair across the desk. A diary helps. A symptom score helps. But neither tells you whether the problem is the bladder failing to hold (Storage Impairment) or the bladder failing to empty (Voiding Impairment). Those two branches of the 4Is framework warrant opposite treatment trajectories. Anticholinergic medication helps Storage; it can be catastrophic in Voiding. Pelvic-floor strengthening helps Storage; it can push a Voiding-impaired bladder into frank retention. Surgery directed at outlet obstruction helps mechanical Voiding; it can worsen detrusor-underactive Voiding.

PVR is the gate-check. The only way to diagnose voiding impairment in this framework is a post-void residual above 100 mL. A diary alone, no matter how well-recorded, cannot make that determination. A symptom score alone cannot make that determination. The two together cannot make that determination. PVR is the singular diagnostic for the Voiding axis, and that singular role is why it sits at the top of the workup hierarchy here rather than as one diagnostic among many.

Decision rule: A complete bladder workup runs diary first to see the volumetric pattern, then PVR to confirm the storage-vs-voiding split. Both are non-invasive, both are inexpensive, both are obtainable in any pelvic-floor clinic or primary-care office with a portable bladder scanner.

Normal versus abnormal post-void residual: what the cutoffs really mean

Five thresholds appear repeatedly in the literature, and they do not all carry the same clinical weight.

| PVR volume | Adult interpretation | IPC clinical action | |---|---|---| | <50 mL | Normal across all consensus sources | Reassure; rule out Voiding axis | | 50 to 100 mL | Normal in clinical practice; "borderline" in some research | Repeat measurement; correlate with symptoms | | 100 to 200 mL | Indeterminate, varies by patient | Investigate cause; correlate with diary | | 200 to 300 mL | Inadequate emptying | Workup cause; consider referral | | >300 mL | Clinically significant retention | Urology referral | | >400 mL | Frank urinary retention | Urology referral, consider catheterisation | | >1,500 mL drained | Severe retention | Monitor for post-obstructive diuresis |

When relief of substantial bladder outlet obstruction drains very large retained volumes, post-obstructive diuresis can become pathologic (Halbgewachs and Domes, Canadian Family Physician 2015).

The split between the research literature's <50 mL cutoff and the clinical-practice <100 mL cutoff matters; consensus on what counts as a clinically significant residual is famously loose (Asimakopoulos et al, Neurourology and Urodynamics 2016).

Studies set the threshold at less than 50 mL. In clinical practice we use less than 100 mL, and we treat anything above 300 mL as risky. The clinical cutoff absorbs measurement variability (timing, scan-machine calibration, patient hydration state) that the research cutoff does not. A 60 mL reading on a portable scanner taken 15 minutes after the void is functionally indistinguishable from a 40 mL reading taken at 5 minutes; treating one as abnormal and the other as normal is testing artefact, not clinical reality.

Age modifies the threshold upward. Older adults run higher PVRs at baseline as detrusor contractility declines and pelvic-floor coordination shifts (Shimoni et al, American Journal of Medicine 2015). A 120 mL PVR in a 45-year-old warrants more concern than the same 120 mL in an 82-year-old. Pediatric thresholds are markedly lower: >20 mL is generally considered abnormal in healthy children (Chang and Yang, Journal of Urology 2009).

A direct read on the People-Also-Ask question: a PVR of 40 mL is normal across every consensus source. A PVR of 200 mL in an adult is not catastrophic but is not nothing; it is the threshold at which the case routes to active investigation rather than reassurance.

How post-void residual is measured, and how it gets measured wrong

Three methods, in descending order of how often they are used in modern outpatient practice.

Portable bladder scanner. A handheld ultrasound device specifically designed for bladder volume estimation. Press button, get number. Non-invasive, painless, takes about 45 seconds per measurement, no risk of UTI or urethral injury. The dominant first-line method in any office with the equipment. Accuracy is good but not catheter-grade. False positives occur with ascites, ovarian cysts, uterine fibroids, severe abdominal scarring, advanced pregnancy, or significant pelvic prolapse (Kim et al, Annals of Rehabilitation Medicine 2017).

Formal bladder ultrasound. Either transabdominal or transvaginal, calculated using the prolate ellipsoid formula length × width × height × 0.52. Slightly more accurate than the portable scanner for low volumes, particularly via transvaginal approach in women. Requires a trained sonographer and the equipment of a formal ultrasound suite, so usually reserved for cases where scanner readings are equivocal.

Urethral catheterisation. The historical gold standard. A 14 or 16 French straight catheter is inserted, the bladder drained, the volume measured directly. Most accurate but invasive. Carries a small but real risk of UTI, with prevalence around 2% reported in studied surgical populations and rising sharply with longer catheter exposure (Karp et al, Female Pelvic Medicine and Reconstructive Surgery 2018), plus a non-zero risk of urethral injury. Reserved now for cases where ultrasound is unavailable, the patient cannot be scanned (massive ascites, late pregnancy), or a urine specimen is needed simultaneously.

The single most common measurement error is timing. PVR rises measurably between minute 5 and minute 30 post-void as the kidneys continue to produce urine, so a delayed measurement inflates the result. The ICS-RS consensus is that the interval between voiding and PVR measurement should be of short duration, with longer intervals causing clinically significant overestimation (Asimakopoulos et al, Neurourology and Urodynamics 2016). A 200 mL PVR taken at 25 minutes may represent a 120 mL true PVR plus 80 mL of subsequent renal output. The fix is procedural: scan immediately, do not let the patient sit in the waiting room between voiding and scanning.

The second most common error is operator-dependent: the scanner needs to centre the bladder in its field. A miscentred scan underestimates large bladders and overestimates small ones. Re-scan if the first reading does not agree with the diary's voided-volume pattern.

Warning: A single PVR is a snapshot of bladder behaviour at one moment. Day-to-day variability is real and well-documented; PVR cannot be reliably determined from one measurement (Dunsmuir et al, British Journal of Urology 1996). A borderline PVR (100 to 200 mL) on a single read warrants a repeat measurement before clinical action.

Reading the bladder diary for PVR clues before you scan

The 3-day frequency-volume chart often shows the PVR signature before the scanner is ever picked up. Three diary patterns predict elevated PVR with reliable specificity in pelvic-health practice.

Frequency with low individual volumes. A patient voiding 10 times per day, total 24-hour voided volume 1,400 mL, mean voided volume 140 mL. The number of voids alone reads as overactive bladder. The voided-volume column tells a different story: the patient is voiding little because the bladder cannot empty completely, so it refills and signals quickly. This is incomplete emptying presenting as urgency.

Double-void notation. When the patient leaves the toilet, returns within five to ten minutes, and produces a second small void, the diary entry reads "100 + 60". The IPC notation uses a plus sign to record the double void. A pattern of plus-signs across the diary, particularly in the morning column when nocturnal urine has accumulated, is a strong predictor of significantly elevated PVR. The Samuel R. case from the IPC library shows the signature cleanly: a daily pattern of incomplete emptying where the patient leaves the toilet thinking voiding is finished, then returns within minutes for another small void.

The "incomplete emptying" check-box. Most well-designed bladder-diary forms include a column for the patient to note sensation of incomplete emptying after each void. The sensation correlates positively with measured PVR, particularly in women across all age groups and in men over 60 (Özlülerden et al, Investigative and Clinical Urology 2018). Repeated incomplete-emptying ticks across a 3-day diary are a useful pre-scan flag.

The point: clinicians without access to a portable scanner are not flying blind. The diary itself cues which patients warrant the scan, and the scan-result rarely surprises a clinician who has read the diary first. For the diary read itself see bladder diary interpretation, and for the volumetric layer that produces the per-void numbers see frequency volume chart.

Causes of high post-void residual, organised by 4Is mechanism

The standard cause list (StatPearls runs to several dozen entries across neurogenic, mechanical, medication, infectious, congenital, anatomic categories) is exhaustive and useful as a reference. For the at-the-bedside read, four mechanism categories cover almost every case the pelvic-floor or primary-care clinician will see.

Mechanical outlet obstruction. Benign prostatic hyperplasia is far and away the most common cause in older men. Urethral stricture, large pelvic-organ prolapse compressing the urethra, and large bladder calculi or tumours fill out the rest of this category. The bladder pump is intact; the outlet resists. Treatment targets the obstruction.

Neurogenic. Diabetic autonomic neuropathy is among the most common neurogenic contributors in the general adult population, given that genitourinary complications outpace neuropathy and nephropathy in prevalence among people with diabetes (Agochukwu-Mmonu et al, Autonomic Neuroscience 2020). Multiple sclerosis, cauda equina syndrome, post-pelvic-surgery denervation, and spinal cord pathology fill out the rest. The bladder pump cannot receive or execute the signal. Treatment depends on the neurology.

Detrusor underactivity (DU). The pump is intact, the signal arrives, the contraction does not generate enough force or last long enough to empty the bladder. Often idiopathic, often age-related, often the residual pattern after years of bladder outlet obstruction left untreated. The underactive bladder is not always a weak bladder; some patients generate a short-term strong contraction that stops abruptly and triggers a second void. DU is heterogeneous in phenotype.

Iatrogenic and medication-induced. Anticholinergics (oxybutynin, tolterodine, the older OAB pharmacology), opioids and anaesthetics, antihistamines with anticholinergic activity, alpha-adrenergic decongestants, tricyclic antidepressants, and certain antimuscarinic medications all reduce detrusor contractility or impair bladder coordination (Verhamme et al, Drug Safety 2008). Post-surgical urinary retention from anaesthesia, pelvic-floor edema, or pain-medication regimens is the inpatient version. This bucket is reversible with deprescribing or time, and is critically the bucket that gets missed when the medication list is not reviewed.

The reason this re-organisation matters is that the treatment trajectory depends on which bucket the patient sits in, and the standard cause-list ordering does not surface the decision. A 300 mL PVR from BPH routes to urology for outlet evaluation. A 300 mL PVR from diabetic cystopathy routes to endocrine optimisation, scheduled voiding, and self-cath training. A 300 mL PVR from idiopathic DU routes to behavioural management and possibly intermittent self-catheterisation. A 300 mL PVR from opioid prescribing routes to medication review. The same number, four different clinical paths.

When elevated post-void residual is overflow incontinence in disguise

The counterintuitive teaching that explains the misdiagnosis: incontinence and retention are not opposite phenomena. They can be the same phenomenon. Not all urinary incontinence calls for immediate treatment of the leak. Sometimes the body is protecting the bladder from failure: the patient cannot void properly, and the leakage is the bladder's safety valve when pressure builds beyond what the urethral closure can hold.

The physiology: when bladder pressure exceeds urethral resistance because the bladder is chronically over-distended, urine leaks out continuously or in small bursts. The patient experiences leakage and, reasonably, reports it as incontinence. The clinician charts urinary incontinence and routes to standard incontinence treatment. The standard treatment, particularly anticholinergic pharmacology aimed at calming detrusor activity, makes the underlying problem worse: it reduces what little contractile force the bladder is generating, increases retention, and increases the overflow leakage the patient came in for.

PVR is the test that catches this misdirection. An incontinent patient with a PVR >200 mL is in the overflow bucket until proven otherwise. The treatment trajectory inverts: scheduled voiding, possibly intermittent self-catheterisation, deprescribing of any anticholinergic on the medication list, urology referral for outlet evaluation. None of this is the standard incontinence pathway, and missing it produces patients who get progressively worse on what looks like guideline-concordant care.

Key insight: Incontinence and retention can be the same phenomenon. The body leaks to relieve a bladder that cannot empty. PVR catches the misdirection before the standard incontinence pathway makes it worse.

The kegel caution: when pelvic-floor strengthening makes post-void residual worse

This is the single most important PT-collaborative pearl in the PVR workup, and the one that does not appear in any of the top-ranked patient-facing PVR articles. Pelvic-floor strengthening prescribed without a prior PVR check can worsen patients with underactive bladder, and in the worst case can push them into frank urinary retention. The 58-year-old from the opening of this article is exactly that pattern: stress-incontinence diagnosis, kegel program, no PVR scan, six weeks later a 280 mL retention picture that the program had been compounding.

The mechanism: pelvic-floor strengthening programs target the urethral closure mechanism. In stress urinary incontinence, that is the right target. In Voiding Impairment from detrusor underactivity, the pelvic-floor and external urethral sphincter are not the problem. Strengthening them adds resistance to a system that is already failing to overcome existing resistance. The bladder, already underperforming on contraction, now has to overcome a tighter urethral closure to void. PVR rises. Retention worsens. New urgency develops as the over-distended bladder fires inappropriately.

The clinical workflow this implies for the pelvic-floor PT: never start a strengthening program for incontinence without a PVR check first. A PVR >100 mL should re-route the case to coordination and relaxation work rather than strengthening, and to a diary review for the Voiding-axis pattern. A PVR >200 mL warrants urology consult before any pelvic-floor program ramps. The cost of getting this wrong is iatrogenic retention in a patient who came in for a leak.

Decision rule: PVR before pelvic-floor strengthening. Always.

Two-finding pattern: diabetes plus chronic low-back pain

A specific risk-stratification pearl worth teaching at every level of the care team. The combination of diabetes and chronic lower back pain is, in our clinical experience, the most common predictor pattern for underactive bladder. Either finding alone raises suspicion. Together, they warrant a PVR scan before any treatment commits.

The physiology is two-hit: diabetes drives autonomic neuropathy that impairs detrusor sensation and contractility, and chronic low-back pathology (spondylosis, spinal stenosis, disc herniation impinging sacral nerve roots) impairs the parasympathetic outflow that drives detrusor contraction. Either alone can cause detrusor underactivity. The combination dramatically raises the pretest probability that a presenting LUTS picture is Voiding Impairment rather than Storage Impairment.

Operationally: when the intake interview surfaces diabetes plus chronic back pain, the workup should run PVR before any treatment commits. The diabetes-plus-back-pain pattern is also a cue to rule out cauda equina with a focused neuro exam (saddle anaesthesia, lower-extremity reflexes, urinary retention) before the workup proceeds (Todd, British Journal of Neurosurgery 2017).

The POCUS bladder-shape sign

A visual pearl from point-of-care ultrasound that takes about 15 seconds to acquire and reads instantly. The normal adult bladder, viewed on transabdominal ultrasound, is roughly spherical when full and ovoid when partially filled. In chronic detrusor underactivity, the bladder remodels: it elongates vertically, the wall thins, the contour becomes notably tall and narrow rather than round. The "tall" bladder has remodelled around years of baseline distension.

This shape difference is recognisable before the volume number is read. With POCUS now standard equipment in primary care, women's-health, and pelvic-floor clinics, it is a pattern worth teaching every clinician who scans a bladder.

The shape sign supplements the volume number. A 220 mL PVR in a round bladder is a different finding from a 220 mL PVR in a tall narrow bladder. The shape signals chronicity.

When post-void residual drives surgery, and when surgery makes post-void residual worse

The most consequential decision PVR drives in male LUTS is the BPH-surgery question. A >300 mL PVR in a man with prostatic outlet obstruction is a strong indication for surgical relief: TURP, prostatic urethral lift, or one of the newer water-vapor or robotic options. A >300 mL PVR in a man with detrusor underactivity is a contraindication, or at minimum a serious caution, against the same surgery.

Underactive bladder responds poorly to outlet surgery and frequently worsens with it. The mechanism: TURP relieves outlet resistance, which helps a strong bladder pump working against an obstacle. It does not help a weak pump that was the actual limiting factor. Worse, post-surgical inflammation transiently impairs detrusor function further; a borderline-functioning bladder can decompensate into frank retention after a procedure that was supposed to relieve it.

The corollary scenario plays out on national health-system surgical waitlists. Patients waiting 7 to 8 months for outlet surgery while carrying an indwelling Foley emerge from the operation to find the bladder no longer remembers how to contract. The chronic indwelling catheter creates iatrogenic detrusor atrophy. The surgical relief that was supposed to fix the patient now arrives at a patient whose pump has decompensated. PVR was not the indication for the surgery; PVR was the warning that the surgical pathway needed to start sooner or take a different route.

The implication for the pre-surgical workup is that PVR plus a urodynamics-derived measure of detrusor contractility (BCI, bladder contractility index) is the right pairing. Operating on PVR alone risks both undertreatment of mechanical obstruction and overtreatment of pump failure.

Beyond post-void residual: pairing with the rest of the workup

PVR is the keystone, not the whole arch. The complete bladder workup that the IPC framework runs in pelvic-health and urology practice combines:

1. 3-day bladder diary. The volumetric and behavioural substrate. See bladder diary interpretation.
2. Functional bladder capacity (largest single voided volume, calculated from the diary). See normal capacity of the bladder.
3. Validated symptom score. ICIQ-LUTS, IPSS for men, OABSS for OAB-suspected presentations.
4. Post-void residual. This article.
5. Uroflowmetry, when available, to characterise voiding pattern and peak flow.
6. Urodynamics, reserved for cases where the above five do not resolve the picture or where surgical decision-making requires it.

The order matters. Diary first because it is non-invasive and reframes most of what the patient came in to discuss. PVR second because it is the singular gate-check on the Voiding axis. Symptom score third for severity quantification. Uroflow and urodynamics later, when warranted by the first three. Running urodynamics first is a common pattern that costs the patient money, time, and sometimes morbidity to confirm what a diary plus a PVR scan would have established cheaper and faster.

The 21-second pee rule and other post-void residual myths

The PAA list shows the "21-second pee rule" repeatedly co-occurring with PVR queries, suggesting users are conflating the two. They measure different things.

The "21-second rule" comes from a 2014 Georgia Tech and Emory study on the law of urination, which observed that mammals weighing more than 3 kg empty their bladders in approximately 21 seconds regardless of body size (Yang et al, Proceedings of the National Academy of Sciences 2014). The mechanism is fluid dynamics: longer urethras in larger animals generate proportionally faster flow, so total void time stays roughly constant.

The rule describes void duration, not void completeness. A patient who voids in 8 seconds and a patient who voids in 35 seconds may both have normal PVRs or both have abnormal PVRs. The rule does not predict retention. It is a useful piece of conversational science, not a clinical diagnostic.

Other PVR myths worth correcting at the bedside:

• "Normal PVR is zero." Not so. Healthy adults retain small volumes between voids, and <100 mL is normal across consensus sources.
• "All retention is BPH." Not so. The four-bucket cause list above shows mechanical obstruction as one of four mechanisms.
• "Ultrasound is always good enough." Mostly true, with the false-positive caveats above. In ascites, severe scarring, or late pregnancy, catheterisation may still be needed.
• "A single high reading is diagnostic." Not so. Day-to-day variability is real. Repeat before treating.

Practical algorithm: refer, manage, or train?

The decision tree at the bedside, after the PVR result is in hand:

PVR <100 mL. The Voiding axis is intact. Reassure regarding emptying. Address Storage symptoms if present (urgency, frequency, nocturia) per the standard 4Is sequence. Pelvic-floor work, behavioural training, fluid management, and Storage-directed pharmacology are all on the table.

PVR 100 to 300 mL, no red flags. Repeat measurement in 2 to 4 weeks before treatment commits, to absorb day-to-day variability. Review the medication list for anticholinergic, opioid, or antihistamine contributors. Bladder diary review for the patterns above. PT-led behavioural management (timed voiding, double-void technique, fluid timing) often resolves this band without urology referral. Pelvic-floor strengthening is contraindicated in this range until coordination and relaxation work has been trialled and the PVR has come down.

PVR >300 mL, no red flags. Urology referral. Continue PT-led behavioural management in the meantime; do not initiate strengthening. Self-catheterisation training may be warranted depending on the urology workup result.

PVR >400 mL, OR any PVR with red flags. Red flags include acute inability to void, suprapubic pain or distension, fever with retention, saddle anaesthesia or new lower-extremity weakness suggesting cauda equina, post-prostatectomy decompensation. Same-day urology evaluation or, for true acute retention, emergency department.

The framing throughout is collaborative across roles. The PT owns behavioural management, double-void coaching, fluid timing, coordination work, and the catch on the pelvic-floor-strengthening trap. The primary care physician owns medication review, glucose check, and the basic neuro exam. The urologist owns outlet evaluation, surgical decision-making, and self-cath training when indicated. The bladder diary plus the PVR scan are the shared interpretive substrate that lets each role read the same numbers and route the case appropriately.

Frequently asked questions

What is a normal post-void residual?

In adults, a PVR <100 mL is considered normal in clinical practice; some research literature uses the stricter <50 mL threshold. Volumes between 100 mL and 200 mL are indeterminate and warrant repeat measurement and clinical correlation. Volumes above 300 mL are clinically significant retention.

What does post-void residual amount mean?

The PVR amount is a measure of how completely the bladder empties on a single void. A higher number means more urine remains in the bladder after the patient feels they have finished urinating, which signals impaired emptying from any of several mechanisms (outlet obstruction, detrusor underactivity, neurogenic, iatrogenic).

What are the risks of a PVR test?

Bladder ultrasound and portable bladder scanning have essentially no risk: no radiation, no invasive component, no contrast. Catheterisation, when used to measure PVR, carries a small but real risk of urinary tract infection (around 2% in studied surgical populations, rising with longer catheter exposure), a small risk of urethral injury, and patient discomfort. Catheterisation for PVR is now reserved for cases where ultrasound is unavailable or unreliable.

What is normal post-void residual by age?

Younger adults run lower PVRs at baseline; healthy adults under 45 typically void to <50 mL. Older adults run higher: a 100 to 150 mL PVR in an 80-year-old may be the patient's stable baseline rather than a pathologic finding. Pediatric thresholds are markedly lower, with >20 mL generally considered abnormal.

Is 200 mL of urine retention bad?

A 200 mL PVR sits in the indeterminate-to-clinically-significant range. It is not an emergency, but it is not nothing. The right next step is repeat measurement in 2 to 4 weeks, medication review, bladder diary review, and avoidance of pelvic-floor strengthening or anticholinergic pharmacology until the cause is clear. Persistent >200 mL warrants urology evaluation.

What is the 21-second pee rule?

The 21-second rule comes from a 2014 study on mammalian urination physics observing that mammals over 3 kg empty their bladders in roughly 21 seconds regardless of body size. It describes void duration, not void completeness, and is not a clinical PVR diagnostic.

How is post-void residual urine treated?

Treatment depends on the cause, not on the PVR number itself. Mechanical obstruction routes to urology for outlet evaluation. Detrusor underactivity routes to behavioural management and, if needed, intermittent self-catheterisation. Medication-induced retention routes to deprescribing. Neurogenic causes route to the underlying neurological workup. There is no single "PVR treatment".

What does post-void residual urine indicate?

Indicates that the bladder is not emptying fully on a single void. The clinical significance depends on the volume retained, the patient's age, the clinical context, and the diary pattern. PVR is a number that points to a question (storage versus voiding axis), not a diagnosis on its own.

Open the bladder diary calculator

For the diary procedure that surfaces incomplete-emptying patterns before any scan, see bladder diary interpretation. For the volumetric layer that produces 24hVV, MVV, and AVV from the diary, see frequency volume chart. For the bladder-capacity reference values that contextualise voided-volume and PVR readings, see normal capacity of the bladder. For the framework that anchors every interpretation, see what is a bladder diary. For the underlying ICS measures, see /definitions.

In my own clinical practice, the bladder workup I most distrust is the one that runs a symptom score, prescribes a treatment, and never checks PVR. The number that ought to direct the storage-versus-voiding split is the one most often missing. The patient on the standard urgency-frequency pathway who is not getting better, or who is getting worse, is the patient whose PVR was not measured before the treatment committed. PVR is 45 seconds on a portable scanner in the same office where the diary was reviewed. The cost of measuring it is rounding error in a clinic visit. The cost of not measuring it is the patient who comes back at three months, six months, twelve months, having gotten worse on what looked like guideline-concordant care. Get the diary, get the PVR, read the pattern, then commit to a treatment axis. That is what we owe them.

Author: Dr. Di Wu, MD, PT (IPC founding member). Medically reviewed by Dr. Steven Tijerina, PT, DPT, Cert. MDT (IPC US Director). Photo: Steve A Johnson on Unsplash.